Recruiting

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on Glycemic Control in Patients With Type 2 Diabetes.

The overall aim of the study is to observe the change of long-term metabolic control in patients with type 2 diabetes who have access to a digital intervention tool as compared with randomized controls during one year. The tool is based on self-affirmation theory and has large emphasis on self-reflection to enable sustainable lifestyle changes. Users get access to expert-written information about relevant health topics and interact with an LLM to promote reflection on the information.

ClinicalTrials.gov IDNCT07079189
PhaseNA
Enrollment300
SponsorRegion Skane
Age35 Years
SexALL
I'm interested View official listing

Conditions studied

Diabetes Mellitus (Type 2)

About this study

The overall aim of the study is to observe the change of long-term metabolic control in patients with type 2 diabetes who have access to a digital intervention tool as compared with randomized controls during one year. The tool is based on self-affirmation theory and has large emphasis on self-reflection to enable sustainable lifestyle changes. Users get access to expert-written information about relevant health topics and interact with an LLM to promote reflection on the information.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Patients with type 2 diabetes * Diagnosis of diabetes mellitus was based on prior documentation or treatment with anti-hyperglycemic medication * age at or above 35 years * access to Internet * informed consent Exclusion Criteria: * Treatment with insulin * Change of anti-diabetic treatment with three months prior to inclusion * Participation in other study that may affect the outcomes * Condition or treatment that in the judgement of the Investigator precludes participation * Inability to read and write in Swedish * Work in competing areas

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.